Insight

Sep 9, 2024, 13:18

Article of the day, September 9th, suggested by the Immune Oncology Research Institute

Immune Oncology Research Institute shared a post on LinkedIn:

“Article of the day! Suggest by the Immune Oncology Research Institute.

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

Authors: John V Reynolds, Shaun R Preston, Brian O’Neill, Prof Maeve A Lowery, Lene Baeksgaard, Thomas Crosby, Moya Cunningham, Sinead Cuffe, Gareth O Griffiths, Imelda Parker, Signe Lenora Risumlund, Rajarshi Roy, Stephen Falk, Prof George B Hanna, Frederick R Bartlett, Alberto Alvarez-Iglesias, Michael P Achiam, Prof Magnus Nilsson, Prof Guillaume Piessen, Narayanasamy Ravi, Prof Dermot O’Toole, Ciaran Johnston, Prof Raymond S McDermott, Richard C Turkington, Shajahan Wahed, Sharmila Sothi, Hugo Ford, Martin S Wadley, Derek Power.

Author Affiliations: Cancer Trials Ireland ,St James’s Hospital Dublin, Royal Surrey NHS Foundation Trust, Velindre N H S Trust, Southampton Clinical Trials Unit, Hull University Teaching Hospitals NHS Trust, University Hospitals Bristol and Weston NHS Foundation Trust, Imperial College Healthcare NHS Trust, Portsmouth Hospitals University NHS Trust, Belfast Health and Social Care Trust, Worcestershire Acute Hospitals NHS Trust, et al.

Source: Immune Oncology Research Institute/LinkedIn

Immune Oncology Research Institute (IMMONC), established in 2022, is a non-profit, independent, patient-centered research institute. The mission of IMMONC is to advance the cancer knowledge and care through breakthrough scientific research, to integrate innovative immune-oncology therapies into the clinical practice for different types of cancers, to generate and collect clinical data for the identification of new therapeutic targets, developing predictive models and optimizing patient outcomes, to increase the availability and accessibility of those discoveries for the cancer patients, to create a world-class professional environment, to attract the brightest minds in cancer field and to train the next generation researchers.

Other posts featuring Immune Oncology Research Institute on OncoDaily.

Alberto Alvarez-Iglesias Article of the day Belfast Health and Social Care Trust Brian O'Neill cancer Cancer Trials Ireland Ciaran Johnston Derek Power Frederick R Bartlett Gareth O Griffiths Hugo Ford Hull University Teaching Hospitals NHS Trust Imelda Parker IMMONC Immune Oncology Research Institute Imperial College Healthcare NHS Trust John V. Reynolds Lene Baeksgaard Martin S Wadley Michael P Achiam Moya Cunningham Narayanasamy Ravi OncoDaily Oncology Portsmouth Hospitals University NHS Trust Prof Dermot O'Toole Prof George B Hanna Prof Guillaume Piessen Prof Maeve A Lowery Prof Magnus Nilsson Prof Raymond S McDermott Rajarshi Roy Richard C Turkington Royal Surrey NHS Foundation Trust Shajahan Wahed Sharmila Sothi Shaun R Preston Signe Lenora Risumlund Sinead Cuffe Southampton Clinical Trials Unit St James's Hospital Dublin Stephen Falk Thomas Crosby University Hospitals Bristol and Weston NHS Foundation Trust Velindre N H S Trust Worcestershire Acute Hospitals NHS Trust

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Bernard Fox received SITC lifetime achievement award

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Special Coverage